期刊文献+

氯沙坦对大鼠离体胸主动脉的舒张作用及机制 被引量:4

Effects of losartan on vascular tone of isolated thoracic aortic rings in rats
下载PDF
导出
摘要 目的:观察氯沙坦对大鼠胸主动脉的舒张作用,并探讨其作用机制。方法:记录氯沙坦对血栓素A2(TXA2)类似物U46619、氯化钾(KCl)预收缩的离体大鼠胸主动脉环作用,观察N-硝基-L-精氨酸甲酯(L-NAME)与吲哚美辛对其作用的影响。结果:氯沙坦(3×10-8~3×10-5 mol/L)对U46619(1μmol/L)预收缩的主动脉环有内皮依赖性的、浓度依赖性的舒张作用。L-NAME(0.1mmol/L)可显著抑制氯沙坦的舒血管作用。吲哚美辛(1μmol/L)对氯沙坦的舒血管作用无明显影响。氯沙坦对KCl(60mmol/L)诱发的血管收缩无明显影响。结论:氯沙坦对U46619引起的血管收缩有浓度依赖性的舒张作用,此作用具有内皮依赖性,与内皮产生的一氧化氮(NO)有关,与前列环素(PGI2)无关。 AIM:To investigate the effects of losartan on the reactivity of the aortic rings in male wistar rats.METHODS: The effects of losartan(3×10-8-3×10-5 mol/L) on rat isolated thoracic aortic rings' contraction induced by TXA2 analog U46619(1 μmol/L) and KCl(60 mmol/L)were observed.In addition,the effect of the NO synthase inhibitor L-NAME(0.1 mmol/L) and the cyclooxygenase inhibitor indomethacin(1μmol/L) on losartan were observed.RESULTS:Losartan(3×10-8-3×10-5 mol/L) reduced the constriction induced by U46619(1 μmol/L) in a dose-dependent and endothelium-dependent manner.L-NAME(0.1 mmol/L)significantly shifted the concentration-response curves of losartan to the right.Indomethacin(1 μmol/L) did not change the relaxations of losartan.Losartan did not significantly affect the constriction induced by KCl(60 mmol/L).CONCLUSION: Losartan preferentially antagonizes contraction induced by U46619 in a dose-dependent and endothelium-dependent manner.The vasorelaxation of losartan is relevant to the production of nitrogen and not relevant to the production of prostaglandin.
出处 《中国临床药理学与治疗学》 CAS CSCD 2011年第11期1252-1256,共5页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 山西省高校科技开发项目(2006107)
关键词 氯沙坦 胸主动脉 血管舒张 U46619 一氧化氮 前列环素 Losartan Angiotasis Vasodilation U46619 Nitrogen Prostaglandin
  • 相关文献

参考文献3

二级参考文献31

共引文献63

同被引文献45

  • 1陈灏珠,樊冰.解读美国心脏病学院及美国心脏学会关于成人慢性心力衰竭评估和治疗指南[J].中华心血管病杂志,2004,32(8):673-675. 被引量:43
  • 2周俊,李东野,陈清枝.大鼠压力负荷性心肌肥厚与氯沙坦及赖诺普利的预防作用[J].中国临床康复,2005,9(19):35-37. 被引量:2
  • 3李懿萍,汪颖南,邓红,苏宁.氯沙坦对高糖状态下内皮细胞的保护作用及其机制探讨[J].浙江大学学报(医学版),2006,35(3):238-244. 被引量:2
  • 4袁伟杰,边琪.心肾综合征的发病及治疗[J].中国中西医结合肾病杂志,2006,7(6):311-313. 被引量:10
  • 5Wang G J, Wu XC, Chen CF, et al. Vasorelaxing action of rutaecarpine: ef{ects o: rutaecarpine on calcium channel activities in vascular endothelial and smooth muscle cells[J]. J Pharmacol Exp Ther , 1999 ,289(3) :1237-1244.
  • 6Kim EY, Kim JH, Rhyu MR. Endothelium-inde- pendent vasorelaxation by ligusticum wallichii in i- solated rat aorta: comparison of a butanolie fraction and tetramethylpyrazine, the main active component of ligusticum wallichii [J]. Biol Pharm Bull, 2010, 33(8) :1360-1363.
  • 7Kitazono T, Faraci FM, Taguchi H, et al. Role of potassium channels in cerebral blood vessels[J]. Stroke, 1995,26(9) : 1713 - 1723.
  • 8Peng W, Hucks D, Priest RM, et al. Ligustrazine- induced endothelium-dependent relaxation in pulmo- nary arteries via an NO-mediated and exogenous L -arginine-dependent mechanism [J]. Br J Pharma- col ,1996, 119(5):1063-1071.
  • 9Sobey CG. Potassium channel function in vascular disease[J]. Arterioscler Thromb Vasc Biol, 2001,21 (1) :28-38.
  • 10Stiles GL, Caron MG, Leftkowitz RJ. 13-Adrenergie receptors: biochemical mechanisms of physiological regulation[J]. Physiol Rev, 1984, 64(2) : 661-743.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部